SCHEMBL4995658

SCHEMBL4995658

O=C(O)[C@@H](O)C[C@H](O)[C@@H](O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
OR51E2 Q9H255 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
PDE4A P27815 1/20 0.42
PGD P52209 1/20 0.41
TET2 Q6N021 6/20 0.40
KDM4A O75164 2/20 0.40
KDM4C Q9H3R0 2/20 0.40
KDM2A Q9Y2K7 2/20 0.40
TET3 O43151 2/20 0.40
TET1 Q8NFU7 1/20 0.37
CYP2C9 P11712 1/20 0.37
GPR84 Q9NQS5 3/20 0.34
PGK1 P00558 1/20 0.34
PGK2 P07205 1/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4995664 1.00 TSHR (0.47) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL12876328 1.00 TSHR (0.47) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL21067861 1.00 TSHR (0.47) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL26138082 0.85 TSHR (0.56) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL26138081 0.84 PDE4A (0.50) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL26138103 0.82 PDE4A (0.60) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL28778993 0.80 TSHR (0.50) TSHROR51E2SMN1; SMN2PDE4APGD
SCHEMBL728172 0.78 OR51E2 (0.59) TSHROR51E2SMN1; SMN2TET2KDM4A
SCHEMBL7856245 0.78 OR51E2 (0.59) TSHROR51E2SMN1; SMN2TET2KDM4A
SCHEMBL19331462 0.78 OR51E2 (0.59) TSHROR51E2SMN1; SMN2TET2KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
US-20200278346-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ADJACENT ACQUISITION CO., LLC 2020-09-03 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 EP disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US disclosed